Stability studies of chitosan-DNA-FAP-B nanoparticles for gene delivery to lung epithelial cells

Zohreh Mohammadi; Farid Dorkoosh; Saman Hosseinkhani; Tina Amini; Amir Rahimi; Abdolhossein Najafabadi; Morteza Tehrani

doi:10.2478/v10007-012-0008-z

.blurhash-client-img { display: none !important; }

Stability studies of chitosan-DNA-FAP-B nanoparticles for gene delivery to lung epithelial cells

Acta Pharmaceutica

Volume 62 (2012): Issue 1 (March 2012)

By: Zohreh Mohammadi, Farid Dorkoosh, Saman Hosseinkhani, Tina Amini, Amir Rahimi, Abdolhossein Najafabadi and Morteza Tehrani

Open Access

|Apr 2012

Abstract

A successful gene delivery system requires efficiency and stability during storage. Stability studies are imperative for nanomedicines containing biotechnological products such as plasmids and targeting peptides. Chitosan-DNA-FAP-B nanoparticles are novel non-viral vectors for specific gene delivery to the lung epithelial cells. In this study, the storage stability of chitosan-DNA-FAP-B nanoparticles at -20, 5 and 24 °C was examined. Size, zeta potential and transfection efficiency of these nano-particles in storage were also evaluated. Stability studies showed that chitosan-DNA-FAP-B nanoparticles were stable after 1 month when stored at -20 °C and retained their initial size, zeta potential and transfection efficiency. However, their stability was not desirable at 5 and 24 °C. Based on these results, it can be concluded that chitosan-DNA-FAP-B nanoparticles can be a promising candidate for gene delivery to lung epithelial cells with good storage stability at -20 °C during 1 month.

References

S. Mansouria, Y. Cuieb, F. Winnikb, Q. Shia, P. Lavignea, M. Benderdoura, E. Beaumonta and J. C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy, Biomaterials 27 (2006) 2060-2065; DOI: 10.1016/j.biomaterials.2005.09.020.10.1016/j.biomaterials.2005.09.020
Search in Google Scholar
Z. Cui and R. J. Mumper, Chitosan-based nanoparticles for topical genetic immunization, J. Control. Release 75 (2001) 409-419; DOI: 10.1016/s0168-3659(01)00407-2.10.1016/S0168-3659(01)00407-2
Search in Google Scholar
F. C. MacLaughlin, R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, M. Hinchcliffe and A. P. Rolland, Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, J. Control. Release 56 (1998) 259-272; DOI: 10.1016/s0168-3659(98)00097-2.10.1016/S0168-3659(98)00097-2
Search in Google Scholar
S. Safari, F. A. Dorkoosh, M. Soleimani, M. H. Zarrintan, H. Akbari, B. Larijani and M. Rafiee Tehrani, N-Diethylmethyl chitosan for gene delivery to pancreatic cancer cells and the relation between charge ratio and biologic properties of polyplexes via interpolations polynomial, Int. J. Pharm. 420 (2011) 350-357; DOI: 10.1016/j.ijpharm.2011.08.050.10.1016/j.ijpharm.2011.08.050
Search in Google Scholar
M. Abolhassani, M. Lagranderie, I. Caminshi, F. Romain, A. Balazuc, M. Wagner, M. Tanguy, L. Fiette, I. Sobhani, G. Milon and G. Marchal, Similar functional activity of dendritic cells recruited to the mesenteric lymph nodes of newborn and adult mice after the rectal delivery of Mycobacterium bovis BCG, Microbes Infect 8 (2006) 2341-2351; DOI: 10.1016/j.micinf.2006.03.022.10.1016/j.micinf.2006.03.022
Search in Google Scholar
Z. Mohammadi, M. Abolhassani, F. A. Dorkoosh, S. Hosseinkhani, K. Gilani, T. Amini, A. Rouholamini Najafabadi and M. Rafiee Tehrani, Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells, Int. J. Pharm. 409 (2011) 307-313; DOI:10.1016/j.ijpharm.2011.02.043.10.1016/j.ijpharm.2011.02.043
Search in Google Scholar
Z. Mohammadi, F. A. Dorkoosh, S. Hosseinkhani, K. Gilani, T. Amini, A. Rouholamini Najafabadi and M. Rafiee Tehrani, In vivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung, Int. J. Pharm. 421 (2011) 183-188; DOI: 10.1016/j.ijpharm.2011.09.029.10.1016/j.ijpharm.2011.09.029
Search in Google Scholar
M. S. Muthu and S. Feng, Pharmaceutical stability aspects of nanomedicines, Nanomedicine 4 (2009) 857-860; DOI:10.2217/nnm.09.75.10.2217/nnm.09.75
Search in Google Scholar
International Conference on Harmonization, ICH Q1A (R2), Stability Testing Guidelines: Stability Testing of New Drug Substances and Products, ICH step 5, CPMP/ICH/2736/99, London 2003.
Search in Google Scholar
F. Romain, A. Laqueyrerie, P. Militzer, P. Pescher, P. Chavarot, M. La-Granderie, G. Auregan, M. Gheorghiu and G. Marchal, Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria, Infect. Immun 61 (1993) 742-750.10.1128/iai.61.2.742-750.1993
Search in Google Scholar
M. Elfinger, J. Geiger, G. Hasenpusch, S. Üzgün, N. Sieverling, M. K. Aneja, C. Maucksch and C. Rudolph, Targeting of the β2-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo, J. Control. Release 135 (2009) 234-241; DOI: 10.1016/j.jcourel.2009.01.012.
Search in Google Scholar
H. Mao, K. Roy, V. Troung-Le, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August and K. W. Leong, Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency, J. Control. Release 70 (2001) 399-421; DOI: 10.1016/s0168-3659(00)00361-8.10.1016/S0168-3659(00)00361-8
Search in Google Scholar
International Conference on Harmonization, ICH Q5C, Stability Testing of Biotechnological/Biological Products, ICH step 4, CPMP/ICH/138/95, London 1996.
Search in Google Scholar
T. Arakawa, S. J. Prestrelski, W. C. Kenney and J. F. Carpenter, Factors affecting short-term and long-term stabilities of proteins, Adv. Drug Deliver. Rev. 46 (2001) 307-326; DOI: 10.1016/s0169-409x(00)00144-7.10.1016/S0169-409X(00)00144-7
Search in Google Scholar
G. Borchard, Chitosans for gene delivery, Adv. Drug Deliver. Rev. 52 (2001) 145-150; DOI: 10.1016/s0169-409x(01)00198-3.10.1016/S0169-409X(01)00198-3
Search in Google Scholar
H. Okamoto, Y. Sakakura, K. Shiraki, K. Oka, S. Nishida, H. Todo, K. Iida and K. Danjo, Stability of chitosan-pDNA complex powder prepared by supercritical carbon dioxide process, Int. J. Pharm 290 (2005) 73-81; DOI: 10.1016/j.ijpharm.2004.11.026.10.1016/j.ijpharm.2004.11.026
Search in Google Scholar
W. Walther, U. Stein, C. Voss, T. Schmidt, M. Schleef and P. M. Schlag, Stability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transfer, Anal. Biochem 318 (2003) 230-235; DOI: 10.1016/s0003-2697(03)00244-6.10.1016/S0003-2697(03)00244-6
Search in Google Scholar
D. M. Prazeres, G. N. M. Ferreira, G. A. Monteiro, C. L. Cooney and J. M. S. Cabral, Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks, Trends Biotechnol. 17 (1999) 169-174; DOI: 10.1016/s0167-7799(98)01291-8.10.1016/S0167-7799(98)01291-8
Search in Google Scholar

Articles in this issue

DOI: https://doi.org/10.2478/v10007-012-0008-z | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 83 - 92

Published on: Apr 3, 2012

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

FAP-B,

Related subjects:

© 2012 Zohreh Mohammadi, Farid Dorkoosh, Saman Hosseinkhani, Tina Amini, Amir Rahimi, Abdolhossein Najafabadi, Morteza Tehrani, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 62 (2012): Issue 1 (March 2012)